Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-{[4-(1-cyclopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a benzenesulfonamide derivative with the chemical formula C18H20N6O2S and a molecular weight of approximately 384.46. It is classified as a small molecule and contains both imidazole and pyrimidine moieties, which are common scaffolds in medicinal chemistry. The compound has been referenced as an experimental agent, but there is no available information on its mechanism of action, clinical development, or approved indications. Its structure suggests potential for antimicrobial or other pharmacological activity typical of sulfonamides, but no specific biological target or therapeutic use has been established in public databases.[1][3][6]
- Other names
- 4-{[4-(3-cyclopropyl-2-methylimidazol-4-yl)pyrimidin-2-yl)amino}-N-methylbenzenesulfonamide
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on 4-{[4-(1-cyclopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-{[4-(1-cyclopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide.